Patents by Inventor Chuanying Xu

Chuanying Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY-DRUG CONJUGATES (ADCS) COMPRISING AN ANTI-TROP-2 ANTIBODY, COMPOSITIONS COMPRISING SUCH ADCS, AS WELL AS METHODS OF MAKING AND USING THE SAME
    Publication number: 20240082415
    Abstract: This disclosure relates to antibody-drug conjugates (ADCs) comprising an anti-Trop-2 antibody. Provided herein are compositions comprising such ADCs, as well as methods of making and using the same.
    Type: Application
    Filed: November 2, 2022
    Publication date: March 14, 2024
    Applicants: Levena (Suzhou) Biopharma Co., Ltd., Shanghai Escugen Biotechnology Co., Ltd.
    Inventors: Tong Zhu, Alisher B. Khasanov, Hui Li, Maojun Guo, Haihong Li, Chuanying Xu, Feng He, Qing Zhou
  • CLDN18.2 ANTIBODY AND USE THEREOF
    Publication number: 20230312704
    Abstract: Provided are an antibody against claudin 18.2 (CLDN18.2) and a use thereof in diagnosing and treating cancer of the stomach, pancreas and esophagus.
    Type: Application
    Filed: February 10, 2021
    Publication date: October 5, 2023
    Inventors: Qing Zhou, Chuanying Xu, Weihong Nian, Xiangyu He, Xinmin Zhang, Xintong Zheng, Feng He, Jing Xiao
  • CLAUDIN 18.2 ANTIBODY AND USE THEREOF
    Publication number: 20230096452
    Abstract: The present invention relates to a claudin 18.2 (CLDN18.2) antibody and the use thereof in treating cancers, such as gastric cancer, pancreatic cancer, and esophageal cancer.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 30, 2023
    Inventors: Qing Zhou, Chuanying Xu, Weihong Nian, Xiangyu He, Xintong Zheng, Xinmin Zhang, Feng He, Jing Xiao
  • HUMAN CD47-TARGETING SINGLE-DOMAIN ANTIBODY AND USE THEREOF
    Publication number: 20230086530
    Abstract: The present application relates to an anti-CD47 single-domain antibody and a use thereof, and a method for preparing the antibody. The single-domain antibody comprises a CDR selected from the following CDRs: (1) CDR1, CDR2, and CDR3 shown by SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO:3; or (2) CDR1, CDR2, and CDR3 shown by SEQ ID NO: 6, SEQ ID NO: 7, and SEQ ID NO: 8.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 23, 2023
    Inventors: Xiangyu He, Weihong Nian, Chuanying Xu, Xintong Zheng, Xinmin Zhang, Jing Xiao, Feng He, Qing Zhou